Paediatric patients (less than age of 17 years) account for less than 1.5% of all prevalent Inflammatory Bowel Disease cases.

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

The prevalence of inflammatory bowel disease (IBD) continues to rise globally, however the true proportion of paediatric IBD patients remains unknown. We conducted an all-age, multiparameter, population-based search using capture-recapture methodology to identify all IBD cases to 31/08/2018 within Lothian, a defined health board and the largest of three within South-East Scotland. Individual case note validation was performed for all 24,601 possible IBD cases according to internationally recognised diagnostic and age criteria. Of 7,035 confirmed point-prevalent patients, 560 were classified as A1 age phenotype at diagnosis, constituting just 8.0% of all cases. 99 patients were less than 17 years of age on 31/08/2018, constituting only 1.4% of all point-prevalent cases. These results demonstrate the true contemporary proportion of prevalent paediatric IBD patients is strikingly low, reflecting compounding prevalence in adult practice and the near-normal life expectancy of this chronic, incurable condition.
Original languageEnglish
JournalJournal of pediatric gastroenterology and nutrition
DOIs
Publication statusPublished - 6 Jul 2020

Fingerprint

Dive into the research topics of 'Paediatric patients (less than age of 17 years) account for less than 1.5% of all prevalent Inflammatory Bowel Disease cases.'. Together they form a unique fingerprint.

Cite this